首页 | 本学科首页   官方微博 | 高级检索  
检索        

左氧氟沙星序贯治疗下呼吸道感染的临床评价
引用本文:杨向新,杜志强,杜伟.左氧氟沙星序贯治疗下呼吸道感染的临床评价[J].临床军医杂志,2007,35(2):237-238.
作者姓名:杨向新  杜志强  杜伟
作者单位:解放军兰州军区乌鲁木齐总医院,呼吸内科,新疆,乌鲁木齐,830000
摘    要:目的评价左氧氟沙星序贯治疗下呼吸道感染(LRTIs)的有效性和安全性。方法采用开放试验,应用左氧氟沙星注射液0.3g治疗30例LRTIs患者,1~2次/d,静脉滴注,4~6d,序贯以0.2g,2次/d,口服,5~9d。结果痊愈率、有效率、细菌清除率分别为63.33%,86.67%,89.29%,不良反应轻微。结论左氧氟沙星序贯治疗下呼吸道感染疗效肯定,安全、经济、方便。

关 键 词:左氧氟沙星  序贯治疗  下呼吸道感染
文章编号:1671-3826(2007)02-0237-02
收稿时间:2007-02-05
修稿时间:2007年2月5日

Clinical Evaluation on Levofloxacin in Sequential Therapy of Lower Respiratory Tract Infection
Yang Xiang-xin,Du Zhi-qiang,Du Wei.Clinical Evaluation on Levofloxacin in Sequential Therapy of Lower Respiratory Tract Infection[J].Clinical Journal of Medical Officer,2007,35(2):237-238.
Authors:Yang Xiang-xin  Du Zhi-qiang  Du Wei
Institution:Department of Respiratory Medicine, Urumqi General Hospital of Lanzhou Military Region, PLA, Urumqi 830000, China
Abstract:Objective To evaluate the efficacy and safety of Cravit (levofloxacin) in the sequential therapy of lower respiratory tract infection (LRTIs). MethodsAn open clinical trial was conducted for the sequential therapy of 30 LRTIs patients with Cravit at a dosage of 0.3 g (qd.~bid., ivgtt.) for 4-6 d and then at a dosage of 0.2 g (bid., p.o.) for 5-9 d.ResultsThe total cure rate was 63.3 %, the total response rate was 86.67 %, and the bacterial clearance rate was 89.29 %. The adverse effect was mild and tolerable. ConclusionCravit is not only effective and safe but also economical and convenient for LRTIs.
Keywords:levofloxacin  sequential therapy  lower respiratory tract infection
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号